Simplify Health Care ETF PINK
40.70 USD +0.07 (+0.16%)
Nov 11, 2026, 10:47 AM EST
40.63 Day range 40.77
32.03 52-week range 41.20
- YTD
- +11.19%
- 1 year
- +18.16%
News
benzinga.com Thermo Fisher Scientific Authorizes $5 Billion Share Buyback after Upbeat Earnings Thermo Fisher Scientific announces new $5 billion share buyback authorization, as traders balance broader market gains against capital plans.
benzinga.com Why Is Eli Lilly Stock Falling Tuesday? Eli Lilly (LLY) falls 2% amid a broader healthcare sell-off. Key support levels, technical breakdown, and market outlook analyzed.
benzinga.com Eli Lilly Jumps As Earnings Beat Meets FDA Tightening Drug Compounding Rules Eli Lilly lifts 2026 outlook after Q1 beat; FDA targets compounded GLP-1 drugs, tightening rules on semaglutide, tirzepatide, liraglutide.
benzinga.com Billionaire Investor Takes New Stake In Thermo Fisher Scientific Loeb buys 50,000 shares in Thermo Fisher Scientific as of Dec. 2025. Recent events: dividend increase, asset sale, Q1 earnings beat, raised guidance
benzinga.com Why Is Eli Lilly Stock Gaining Today? Eli Lilly shares surged after FDA approval of its oral obesity drug Foundayo, boosting growth prospects in the weight-loss market.
benzinga.com What's Going On With Biohaven Stock On Monday? Biohaven shares rose in premarket trading after Xenon's Phase 3 epilepsy study showed strong seizure reduction results.
benzinga.com Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients Eli Lilly's lung cancer trial shows lower recurrence risk and strong survival benefit in early-stage patients.
benzinga.com United Therapeutics Reports Early Success For External Liver Support In Acute Failure United Therapeutics' external liver assist product shows positive results in phase 1 study for acute liver failure patients.
benzinga.com Beyond Oil And Gold: Can We Expect A Surge In 'Crisis Alpha' ETFs Amid Israel-Iran Tensions? Middle East conflict boosts demand for 'crisis alpha' ETFs in defense, energy, inflation, and cybersecurity sectors, as investors fear market volatility.
benzinga.com World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding, reigniting a past debate.
benzinga.com Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.